検体採集カードの世界市場

検体採集カードの世界市場は2030年までに5億5,970万米ドルに達する見込み

2024年に4億5,080万米ドルと推定される検体採集カードの世界市場は、2024～2030年の分析期間にCAGR 3.7%で成長し、2030年には5億5,970万米ドルに達すると予測されます。本レポートで分析したセグメントの1つである血液は、CAGR 3.7％を記録し、分析期間終了時には2億2,110万米ドルに達すると予測されています。唾液セグメントの成長率は、分析期間中CAGR 2.9％と推定されます。

米国市場は1億2,280万米ドルと推定、中国はCAGR6.8％で成長予測

米国の検体採集カード市場は2024年に1億2,280万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを6.8%として、2030年までに1億1,230万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.5%と2.8%と予測されています。欧州では、ドイツがCAGR 2.1%で成長すると予測されています。

世界の検体採集カード市場- 主要動向と促進要因のまとめ

現代の診断において検体採集カードが重要性を増している理由とは？

検体採集カードは、主に生物学的サンプルの収集、保存、輸送を簡素化する能力により、現代の医療診断、公衆衛生監視、生物医学研究において不可欠なツールとなっています。これらのカードは、乾燥血液スポット（DBS）、唾液、頬側細胞、その他の生物学的液体を、処理された紙や膜に採取・保存するように設計されており、特に遠隔地や資源が限られた環境において、侵襲性が低く、低コストで、ロジカルに効率的なサンプル採取のソリューションを提供します。世界のヘルスケアシステムが分散化と予防医療にますます重点を置くようになる中、検体採集カードの使用は、新生児スクリーニング、感染症モニタリング、遺伝子検査、法医学分析、さらには個別化医療などの用途で拡大しています。常温での安定性により、コールドチェーン物流が不要となり、複雑さとコストの両方が削減されます。さらに、パンデミック時代には郵送検査や自宅でのサンプル採取が重視されたため、スケーラブルな診断やバイオサーベイランス戦略の一環として検体採集カードが脚光を浴びるようになりました。臨床試験であれ、フィールドベースの疫学であれ、遠隔医療環境であれ、これらのカードは、より利用しやすく強靭な健康モニタリングフレームワークへの世界のシフトをサポートしています。

カードデザインと検体の安定性における革新は、どのように市場導入を促進しているのか？

ろ紙治療、分析物の安定化、複数サンプルの統合における技術的進歩は、検体採集カードの機能を変革しています。メーカーは現在、核酸（DNA、RNA）やタンパク質をより効果的に保存し、保存期間を延ばし、さまざまな環境条件下での分析物の完全性を向上させる、強化されたケミカルコーティングを施したカードを製造しています。容量確認用の指示色素を埋め込んだカードもあり、自宅検査や現場環境でのユーザーによる十分で一貫したサンプル採取を保証します。その他の革新的技術には、さまざまなサンプルタイプに対応するマルチゾーン・コレクション・エリア、トレーサビリティのための統合バーコード、法医学的および臨床的使用のための規制コンプライアンスに適合するタンパーエビデント・パッケージングなどがあります。最も広く使用されている乾燥血液スポットカードは、PCR、質量分析、ELISA、次世代シーケンシング（NGS）などの下流アプリケーションに最適化されつつあり、高感度診断ワークフローに適合しています。また、検査室での処理を合理化するために、自動化対応のフォーマットも開発されています。これらの製品レベルの改良により、検体採集カードはより汎用性が高く、ユーザーフレンドリーで、世界の診断薬サプライチェーンとの互換性が高くなっています。

需要が最も伸びている場所と、どの使用事例が成長をリードしているか？

検体採集カードに対する需要は、臨床、研究、公衆衛生の各分野で急速に高まっており、特に新生児スクリーニング、感染症診断、遺伝子検査などの用途で大きな伸びを示しています。新生児スクリーニング・プログラムは、特に北米、欧州、アジア太平洋地域の一部において、乾燥血液スポットカードの最大かつ最も確立されたユーザーであり続けており、そこでは代謝異常や遺伝子異常の検査が日常的に行われています。HIV、肝炎、結核の早期発見プログラムの世界の拡大も、従来の瀉血や冷蔵サンプル輸送が制限される発展途上国でのカード利用を促進しています。直接消費者向け（DTC）遺伝子検査会社は、自宅採取カードをキットに組み入れることが増えており、顧客は家系、キャリア・スクリーニング、ウェルネス・レポートのために唾液や頬のぬぐい液サンプルを提出することができます。バイオバンクや縦断的コホート研究は、検体カードを使用して、コンパクトで費用効果の高い方法で、大規模集団から検体を収集、保管、保存しています。薬理ゲノミクス、法医学毒物学、治療薬モニタリングのような新しい分野も、非侵襲的でスケーラブルなサンプリングのためにこれらのツールを採用しています。政府、NGO、学術研究者は、特に大量サンプリングとサーベイランスが迅速かつ効率的に必要とされる世界の健康危機の後、総体的に需要に貢献しています。

検体採集カード市場の長期的成長の原動力は？

検体採集カード市場の成長は、世界ヘルスの優先事項、診断の分散化、技術革新、規制の進化と結びついたいくつかの連動した要因によってもたらされます。主要な促進要因は、早期診断、発生追跡、個別治療をサポートするスケーラブルで費用対効果の高いサンプル収集ツールに対するニーズの高まりです。在宅ヘルスケア、遠隔患者モニタリング、デジタル診断へのシフトは、従来のヘルスケア環境以外での検体採取のための基礎的ツールとして、検体カードの関連性をさらに拡大させています。遺伝子検査、臨床研究、バイオバンクへの投資の増加は、分析物の完全性が高く、下流の分子ワークフローと互換性のあるサンプルを保存できるカードへの長期的な需要を生み出しています。これと並行して、公衆衛生機関は、検体カードを疫学調査やワクチン接種のモニタリングに統合し、集団の健康管理における検体カードの役割を強化しています。乾燥血液スポットや代替検体カードが臨床グレードのデータ源として有効であるという規制当局の認識も、診断における検体カードの使用を正常化するのに役立っています。健康の公平性、疾病予防、迅速な対応能力が世界的に注目される中、検体採集カードは、世界のどこにいても患者と検査室間のギャップを埋める重要なイネーブラーであり続けるでしょう。

セグメント

検体（血液、唾液、尿、頬細胞、その他）、材料（コットン＆セルロースベース、ファイバーベース、その他）、用途（新生児スクリーニング、感染症検査、治療薬モニタリング、法医学、調査、ウェルビーイング／健康モニタリング、その他の用途）

調査対象企業の例

• Ahlstrom-Munksjo
• ARCHIMEDlife
• Becton, Dickinson and Company（BD）
• Capitainer AB
• Cardinal Health
• CENTOGENE N.V.
• DBS System SA
• Eastern Business Forms, Inc.（EBF）
• EUROIMMUN AG
• F. Hoffmann-La Roche Ltd
• GenTegra LLC
• Greiner Bio-One International GmbH
• Hemaxis
• Lipomic Healthcare
• Medline Industries, LP
• Mitra Microsampling Devices（Neoteryx）
• Munktell Filter AB
• Neoteryx LLC
• PerkinElmer, Inc.
• Phenomenex, Inc.
• QIAGEN N.V.
• RDA Spot
• SARSTEDT AG & Co. KG
• Shimadzu Scientific Instruments
• Sirchie Acquisition Company, LLC
• Synergy Medical Systems LLP
• Thomas Scientific
• VWR International, LLC
• Whatman（part of Cytiva）

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Specimen Collection Cards Market to Reach US$559.7 Million by 2030

The global market for Specimen Collection Cards estimated at US$450.8 Million in the year 2024, is expected to reach US$559.7 Million by 2030, growing at a CAGR of 3.7% over the analysis period 2024-2030. Blood, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$221.1 Million by the end of the analysis period. Growth in the Saliva segment is estimated at 2.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$122.8 Million While China is Forecast to Grow at 6.8% CAGR

The Specimen Collection Cards market in the U.S. is estimated at US$122.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$112.3 Million by the year 2030 trailing a CAGR of 6.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 2.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global Specimen Collection Cards Market - Key Trends & Drivers Summarized

Why Are Specimen Collection Cards Gaining Critical Importance in Modern Diagnostics?

Specimen collection cards have become an essential tool in modern medical diagnostics, public health surveillance, and biomedical research, primarily due to their ability to simplify biological sample collection, preservation, and transportation. Designed to collect and store dried blood spots (DBS), saliva, buccal cells, or other biological fluids on treated paper or membranes, these cards offer a minimally invasive, low-cost, and logistically efficient solution for sample acquisition-especially in remote or resource-limited settings. With global healthcare systems increasingly focused on decentralization and preventive care, the use of specimen collection cards is expanding across applications such as newborn screening, infectious disease monitoring, genetic testing, forensic analysis, and even personalized medicine. Their stability at ambient temperatures eliminates the need for cold-chain logistics, reducing both complexity and cost. Moreover, the pandemic-era emphasis on mail-in testing and at-home sample collection has brought specimen collection cards into the spotlight as part of scalable diagnostics and bio-surveillance strategies. Whether in clinical trials, field-based epidemiology, or telehealth settings, these cards are supporting the global shift toward more accessible and resilient health monitoring frameworks.

How Are Innovations in Card Design and Sample Stability Enhancing Market Adoption?

Technological advancements in filter paper treatment, analyte stabilization, and multi-sample integration are transforming the capabilities of specimen collection cards. Manufacturers are now producing cards with enhanced chemical coatings that preserve nucleic acids (DNA, RNA) and proteins more effectively, extending shelf life and improving the integrity of analytes under varied environmental conditions. Some cards are embedded with indicator dyes for volume verification, ensuring sufficient and consistent sample collection by users in home-testing or field environments. Other innovations include multi-zone collection areas for different sample types, integrated barcoding for traceability, and tamper-evident packaging that meets regulatory compliance for forensic and clinical use. Dried blood spot cards, the most widely used format, are increasingly optimized for downstream applications such as PCR, mass spectrometry, ELISA, and next-generation sequencing (NGS), thereby aligning with high-sensitivity diagnostic workflows. Automation-compatible formats are also being developed to streamline laboratory processing. These product-level improvements are making specimen collection cards more versatile, user-friendly, and compatible with global diagnostic supply chains-key factors in enabling broader adoption in both high-throughput laboratories and point-of-care environments.

Where Is Demand Rising Fastest, and Which Use Cases Are Leading Growth?

Demand for specimen collection cards is rising rapidly across clinical, research, and public health sectors, with particularly strong growth in applications such as newborn screening, infectious disease diagnostics, and genetic testing. Newborn screening programs remain the largest and most established user of dried blood spot cards, especially in North America, Europe, and parts of Asia-Pacific, where testing for metabolic and genetic disorders is routine. The global expansion of early detection programs for HIV, hepatitis, and tuberculosis is also driving card usage in developing countries, where conventional phlebotomy and refrigerated sample transport may be limited. Direct-to-consumer (DTC) genetic testing companies are increasingly incorporating at-home collection cards into their kits, allowing customers to submit saliva or cheek swab samples for ancestry, carrier screening, or wellness reports. Biobanks and longitudinal cohort studies are using specimen cards to collect, store, and archive samples from large populations in a compact, cost-effective manner. Emerging areas like pharmacogenomics, forensic toxicology, and therapeutic drug monitoring are also adopting these tools for non-invasive, scalable sampling. Governments, NGOs, and academic researchers are collectively contributing to demand, particularly in the wake of global health crises where mass sampling and surveillance are needed quickly and efficiently.

What’s Driving the Long-term Growth of the Specimen Collection Cards Market?

The growth in the specimen collection cards market is driven by several interlinked factors tied to global health priorities, diagnostic decentralization, technological innovation, and regulatory evolution. A primary driver is the rising need for scalable, cost-effective sample collection tools that support early diagnosis, outbreak tracking, and personalized treatment-especially in low-resource or geographically dispersed populations. The shift toward home-based healthcare, remote patient monitoring, and digital diagnostics is further expanding the relevance of specimen cards as foundational tools for sample acquisition outside traditional healthcare settings. Increased investment in genetic testing, clinical research, and bio-banking is creating long-term demand for cards that can store samples with high analyte integrity and compatibility with downstream molecular workflows. In parallel, public health agencies are integrating specimen cards into epidemiological studies and vaccination monitoring, reinforcing their role in population health management. Regulatory recognition of dried blood spot and alternative specimen cards as valid sources for clinical-grade data is also helping to normalize their use in diagnostics. As global focus intensifies on health equity, disease prevention, and rapid response capabilities, specimen collection cards are set to remain a vital enabler-bridging the gap between patients and laboratories, wherever they are in the world.

SCOPE OF STUDY:

The report analyzes the Specimen Collection Cards market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Specimen (Blood, Saliva, Urine, Buccal Cells, Others); Material (Cotton & Cellulose-based, Fiber-based, Others); Application (New Born Screening, Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

• Ahlstrom-Munksjo
• ARCHIMEDlife
• Becton, Dickinson and Company (BD)
• Capitainer AB
• Cardinal Health
• CENTOGENE N.V.
• DBS System SA
• Eastern Business Forms, Inc. (EBF)
• EUROIMMUN AG
• F. Hoffmann-La Roche Ltd
• GenTegra LLC
• Greiner Bio-One International GmbH
• Hemaxis
• Lipomic Healthcare
• Medline Industries, LP
• Mitra Microsampling Devices (Neoteryx)
• Munktell Filter AB
• Neoteryx LLC
• PerkinElmer, Inc.
• Phenomenex, Inc.
• QIAGEN N.V.
• RDA Spot
• SARSTEDT AG & Co. KG
• Shimadzu Scientific Instruments
• Sirchie Acquisition Company, LLC
• Synergy Medical Systems LLP
• Thomas Scientific
• VWR International, LLC
• Whatman (part of Cytiva)

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Specimen Collection Cards - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Growing Emphasis on Early Disease Detection Throws the Spotlight on Specimen Collection Cards as Critical Diagnostic Tools
  • Rising Demand for At-home and Remote Testing Spurs Growth in Dried Blood Spot (DBS) and Saliva-based Collection Card Use
  • Here's How Newborn Screening Programs Expand the Addressable Market for Standardized Specimen Collection Cards
  • Decentralized and Mobile Healthcare Models Strengthen the Business Case for Easy-to-use, Ambient-stable Collection Formats
  • Increased Use in Genomic and Biomarker-based Studies Propels Innovation in Multi-analyte-compatible Collection Cards
  • Here's the Story: Infectious Disease Surveillance and Pandemic Preparedness Initiatives Drive Public Sector Procurement
  • Integration with Telehealth and Mail-in Lab Testing Platforms Accelerates Adoption in Consumer-facing Diagnostics
  • Rising Demand for Sample Integrity and Traceability Fuels Growth of Barcoded and Pre-labeled Collection Cards
  • Here's How Advancements in Sample Preservation Technologies Enable Long-term Storage Without Cold Chain Requirements
  • Global Expansion of Biobanking and Population-scale Research Projects Generates Demand for High-quality Collection Cards
  • Point-of-care and Field Testing Applications Sustain Growth in Remote, Resource-limited, and Emergency Settings
  • Here's How Personalized Medicine and Direct-to-consumer Testing Trends Create Opportunities for Specialty Specimen Cards
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Specimen Collection Cards Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Specimen Collection Cards by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Specimen Collection Cards by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Specimen Collection Cards by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Blood by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Blood by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Blood by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Saliva by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Saliva by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Saliva by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Urine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Urine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Urine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Buccal Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Buccal Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Buccal Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other Specimens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other Specimens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Other Specimens by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Infectious Diseases Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Infectious Diseases Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Infectious Diseases Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Therapeutic Drug Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Therapeutic Drug Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Therapeutic Drug Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Forensics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Forensics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Forensics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Wellbeing / Health Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Wellbeing / Health Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Wellbeing / Health Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for New Born Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for New Born Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for New Born Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Cotton & Cellulose-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Cotton & Cellulose-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Cotton & Cellulose-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Fiber-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Fiber-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Fiber-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 47: World Recent Past, Current & Future Analysis for Other Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 48: World Historic Review for Other Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: World 15-Year Perspective for Other Materials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Specimen Collection Cards Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 50: USA Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: USA 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
  • TABLE 56: USA Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: USA Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: USA 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: Canada 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
  • TABLE 65: Canada Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Canada Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: Canada 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
• JAPAN
  • Specimen Collection Cards Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: Japan 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
  • TABLE 74: Japan Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Japan Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: Japan 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
• CHINA
  • Specimen Collection Cards Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 77: China Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
  • TABLE 80: China Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: China 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
  • TABLE 83: China Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: China Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: China 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
• EUROPE
  • Specimen Collection Cards Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Specimen Collection Cards by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Specimen Collection Cards by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Specimen Collection Cards by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: Europe 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: Europe 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
• FRANCE
  • Specimen Collection Cards Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 98: France Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: France Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: France 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
  • TABLE 101: France Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: France Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: France 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
  • TABLE 104: France Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: France Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: France 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
• GERMANY
  • Specimen Collection Cards Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 107: Germany Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Germany Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: Germany 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
  • TABLE 110: Germany Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Germany Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: Germany 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
  • TABLE 113: Germany Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Germany Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: Germany 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 116: Italy Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Italy Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: Italy 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
  • TABLE 119: Italy Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Italy Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: Italy 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
  • TABLE 122: Italy Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Italy Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: Italy 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Specimen Collection Cards Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 125: UK Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: UK Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: UK 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
  • TABLE 128: UK Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: UK Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: UK 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
  • TABLE 131: UK Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: UK Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: UK 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 134: Spain Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Spain Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Spain 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
  • TABLE 137: Spain Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Spain Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Spain 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
  • TABLE 140: Spain Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Spain Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: Spain 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 143: Russia Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Russia Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: Russia 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
  • TABLE 146: Russia Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Russia Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: Russia 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
  • TABLE 149: Russia Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Russia Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: Russia 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Rest of Europe Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Rest of Europe 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
  • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Rest of Europe Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Rest of Europe 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
  • TABLE 158: Rest of Europe Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Rest of Europe Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Rest of Europe 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Specimen Collection Cards Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Specimen Collection Cards by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Specimen Collection Cards by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 15-Year Perspective for Specimen Collection Cards by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Asia-Pacific Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: Asia-Pacific 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
  • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Asia-Pacific Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: Asia-Pacific 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
  • TABLE 170: Asia-Pacific Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Asia-Pacific Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: Asia-Pacific 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Specimen Collection Cards Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 173: Australia Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Australia Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: Australia 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
  • TABLE 176: Australia Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Australia Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: Australia 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
  • TABLE 179: Australia Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Australia Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: Australia 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
• INDIA
  • Specimen Collection Cards Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 182: India Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: India Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: India 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
  • TABLE 185: India Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: India Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: India 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
  • TABLE 188: India Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: India Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: India 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 191: South Korea Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: South Korea Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: South Korea 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
  • TABLE 194: South Korea Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: South Korea Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: South Korea 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
  • TABLE 197: South Korea Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: South Korea Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: South Korea 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Asia-Pacific Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Rest of Asia-Pacific 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
  • TABLE 203: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Rest of Asia-Pacific Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Rest of Asia-Pacific 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
  • TABLE 206: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Rest of Asia-Pacific Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Rest of Asia-Pacific 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Specimen Collection Cards Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Specimen Collection Cards by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Specimen Collection Cards by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Latin America 15-Year Perspective for Specimen Collection Cards by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 212: Latin America Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Latin America Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Latin America 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
  • TABLE 215: Latin America Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Latin America Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: Latin America 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
  • TABLE 218: Latin America Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Latin America Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: Latin America 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 221: Argentina Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Argentina Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: Argentina 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
  • TABLE 224: Argentina Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Argentina Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: Argentina 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
  • TABLE 227: Argentina Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Argentina Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: Argentina 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 230: Brazil Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Brazil Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: Brazil 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
  • TABLE 233: Brazil Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Brazil Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: Brazil 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
  • TABLE 236: Brazil Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Brazil Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: Brazil 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 239: Mexico Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Mexico Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: Mexico 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
  • TABLE 242: Mexico Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Mexico Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Mexico 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
  • TABLE 245: Mexico Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Mexico Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Mexico 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Latin America Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Latin America 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
  • TABLE 251: Rest of Latin America Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Latin America Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Rest of Latin America 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
  • TABLE 254: Rest of Latin America Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Rest of Latin America Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Rest of Latin America 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Specimen Collection Cards Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Specimen Collection Cards by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Specimen Collection Cards by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Middle East 15-Year Perspective for Specimen Collection Cards by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 260: Middle East Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Middle East Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Middle East 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
  • TABLE 263: Middle East Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Middle East Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Middle East 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
  • TABLE 266: Middle East Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Middle East Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Middle East 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 269: Iran Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Iran Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Iran 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
  • TABLE 272: Iran Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Iran Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Iran 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
  • TABLE 275: Iran Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Iran Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: Iran 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 278: Israel Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Israel Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: Israel 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
  • TABLE 281: Israel Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Israel Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: Israel 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
  • TABLE 284: Israel Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Israel Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: Israel 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Saudi Arabia Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: Saudi Arabia 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
  • TABLE 290: Saudi Arabia Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Saudi Arabia Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: Saudi Arabia 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
  • TABLE 293: Saudi Arabia Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Saudi Arabia Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: Saudi Arabia 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 296: UAE Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: UAE Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: UAE 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
  • TABLE 299: UAE Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: UAE Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: UAE 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
  • TABLE 302: UAE Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: UAE Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 304: UAE 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Middle East Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Middle East 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
  • TABLE 308: Rest of Middle East Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Middle East Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Middle East 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
  • TABLE 311: Rest of Middle East Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Rest of Middle East Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 313: Rest of Middle East 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030
• AFRICA
  • Specimen Collection Cards Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 314: Africa Recent Past, Current & Future Analysis for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Africa Historic Review for Specimen Collection Cards by Specimen - Blood, Saliva, Urine, Buccal Cells and Other Specimens Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 316: Africa 15-Year Perspective for Specimen Collection Cards by Specimen - Percentage Breakdown of Value Sales for Blood, Saliva, Urine, Buccal Cells and Other Specimens for the Years 2015, 2025 & 2030
  • TABLE 317: Africa Recent Past, Current & Future Analysis for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Africa Historic Review for Specimen Collection Cards by Application - Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 319: Africa 15-Year Perspective for Specimen Collection Cards by Application - Percentage Breakdown of Value Sales for Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing / Health Monitoring, Other Applications and New Born Screening for the Years 2015, 2025 & 2030
  • TABLE 320: Africa Recent Past, Current & Future Analysis for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Africa Historic Review for Specimen Collection Cards by Material - Cotton & Cellulose-based, Fiber-based and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 322: Africa 15-Year Perspective for Specimen Collection Cards by Material - Percentage Breakdown of Value Sales for Cotton & Cellulose-based, Fiber-based and Other Materials for the Years 2015, 2025 & 2030

IV. COMPETITION